Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05735080 |
| Title | Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer (INX-315-01) |
| Acronym | INX-315-01 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Incyclix Bio |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Emory Winship Cancer Institute | RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
| Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| Levine Cancer Institute (LCI)- Atrium Health | RECRUITING | Charlotte | North Carolina | 28204 | United States | Details |
| Duke Cancer Center/ DUMC | RECRUITING | Durham | North Carolina | 27705 | United States | Details |
| Gabrail Cancer Research Center | RECRUITING | Canton | Ohio | 44718 | United States | Details |
| Peter MacCallum Cancer Center | RECRUITING | Parkville | Victoria | 3052 | Australia | Details |
| Mater Hospital | RECRUITING | South Brisbane | 4101 | Australia | Details |